Idexx Laboratories ( (IDXX) ) has shared an announcement.
On February 13, 2025, Dr. Asha Collins resigned from the Board of Directors of Idexx Laboratories, Inc., effective immediately. Her resignation was not due to any disagreements with the company regarding its operations, policies, or practices. Consequently, the board size was reduced from ten to nine directors, as the company expressed gratitude for Dr. Collins’s contributions and wished her well in her future endeavors.
More about Idexx Laboratories
Idexx Laboratories operates within the healthcare industry, specializing in veterinary diagnostics and information technology solutions. The company focuses on providing innovative products and services that enhance the health and well-being of pets and livestock, positioning itself as a leader in the veterinary sector.
YTD Price Performance: 12.45%
Average Trading Volume: 653,426
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $37.65B
Learn more about IDXX stock on TipRanks’ Stock Analysis page.